Top Markets
Coin of the day
Bright Minds Biosciences Inc. Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc.

DRUG
Ранг среди акций #11319
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics... Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company’s BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.
Цена акции
$73.12
Последняя синхронизация: 2026-08-28
Рыночная капитализация
$715.61M
Изменение (1 день)
-1.90%
Изменение (1 год)
88.01%
Страна
US
Торговля Bright Minds Biosciences Inc. (DRUG)

Категория

История цены акций Bright Minds Biosciences Inc. (DRUG)
Наивысшая цена закрытия: $78.82 2026-08-01

Наименьшая цена закрытия: $26.78 2021-03-01
История цены акций Bright Minds Biosciences Inc. с 2021 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -9.92%
2025 104.69%
2024 2,591.40%
2023 -68.68%
2022 -73.75%
2021 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH